Pricing Log in Create free account
Friday 6 November 2026 Export IRTC’s income statement to Excel — free account

iRhythm Holdings, Inc.

IRTC Healthcare Medical Devices

iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.

Revenue
+14.9%
EPS
−462.5%
Free cash flow
−157.6%
Total debt
+0.48%

Quarter to September 2026, against a year earlier

90.26 39.93 −30.67%
Market cap
$4.3B
P/E
0.0×
Fwd P/E
−311×
Dividend yield
—
F-score
5/9
Altman Z
4.02
Beneish M
−3.04
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

iRhythm Holdings, Inc. (IRTC) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, iRhythm Holdings, Inc. (IRTC) trades at a EV/Sales of 5.2×. Over the past ten years it has ranged from 1.1× (November 2016) to 28.7× (November 2020); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 7.7× 55.33%
FY2024 5.0× (18.72%)
FY2023 6.1× (5.30%)
FY2022 6.4× (35.68%)
FY2021 10.0× (57.71%)
FY2020 23.7× 214.75%
FY2019 7.5× (31.48%)
FY2018 11.0× (11.80%)
FY2017 12.5× 843.00%
FY2016 1.3× 13.21%

Quarterly newest first

Period EV/Sales Change
Sep 2026 4.5× (6.26%)
Jun 2026 4.8× (3.69%)
Mar 2026 5.0× (34.94%)
Dec 2025 7.7× (3.82%)
40 more quarters

Against its own ten years

Low 1.1× High 28.7×
Ten-year median 8.4×
Current reading's percentile 18

EV/Sales against peers

Company EV/Sales
ITGR Integer Holdings Corporation compare 3.0×
LIVN LivaNova PLC compare 3.2×
NEOG Neogen Corporation compare 3.6×
UFPT UFP Technologies, Inc. compare 3.7×
TMDX TransMedics Group, Inc. compare 3.8×
HAE Haemonetics Corporation compare 4.7×
IRTC iRhythm Holdings, Inc. 5.2×
AXGN AxoGen, Inc. compare 8.8×
TXG 10x Genomics compare 11.5×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on IRTC